Iovance Biotherapeutics Stock Forecast

Buy candidate since Jul 15, 2026 Gain 5.91%

The Iovance Biotherapeutics, Inc. stock price gained 0.400% on the last trading day (Monday, 20th Jul 2026), rising from $5.00 to $5.02. During the last trading day the stock fluctuated 6.56% from a day low at $4.81 to a day high of $5.12. The price has been going up and down for this period, and there has been a 19.81% gain for the last 2 weeks. Volume fell on the last day by -7 million shares and in total, 16 million shares were bought and sold for approximately $81.72 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $5.00, a level that may pose a second chance to hit a runner. According to fan-theory $5.76 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

IOVA Signals & Forecast

Mostly positive signals in the chart today. The Iovance Biotherapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $4.52 and $4.19. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 32.80%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Iovance Biotherapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $4.74 and $4.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Iovance Biotherapeutics, Inc. finds support just below today's level at $4.74. If this is broken, then the next support from accumulated volume will be at $4.25 and $4.10.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.315 between high and low, or 6.56%. For the last week, the stock has had daily average volatility of 12.58%.

Our recommended stop-loss: $4.86 (-3.20%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 26 days ago.)

Trading Expectations (IOVA) For The Upcoming Trading Day Of Tuesday 21st

For the upcoming trading day on Tuesday, 21st we expect Iovance Biotherapeutics, Inc. to open at $4.98, and during the day (based on 14 day Average True Range), to move between $4.83 and $5.21, which gives a possible trading interval of +/-$0.381 (+/-7.88%) up or down from last closing price. If Iovance Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.88% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $4.74, some $0.280 (5.58%) from the current price of $5.02, our system finds the risk reward attractive.

Is Iovance Biotherapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and the stock has broken the rising trend up, which indicates an even stronger rate of rising. We can conclude that the current level may hold a buying opportunity as there is a fair chance for Iovance Biotherapeutics, Inc. stock to perform well in the short-term period. Due to a possible false trend-break listing stock as pure buy candidate is held back. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.

Current score: 3.681 Buy Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 21, 2026 - $4.98 ( 0.764%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk